Recon: FDA approves first two biosimilars to Regeneron’s Eylea; Neuralink cleared to implant brain chip in second patient
ReconJason Scott
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicySubmission and registrationUnited States